Tabitha Garrison
Pain Medicine · Broadway, VANPI 1205990983
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 324 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,462, more than ten times the $53 reported in 2020.
Across 324 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$1K
- Pfizer$731
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$392
- Biohaven Pharmaceutical Holding Company Ltd.$387
- AbbVie$327
- Boston Scientific$229
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,111100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 69 | $1,045 |
| Pfizer | 66 | $731 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $392 |
| Biohaven Pharmaceutical Holding Company Ltd. | 28 | $387 |
| AbbVie | 16 | $327 |
| Boston Scientific | 5 | $229 |
| Vertex | 7 | $204 |
| Lilly USA, LLC | 11 | $191 |
| Biohaven Pharmaceuticals, Inc. | 17 | $189 |
| GRT US Holding, Inc. | 8 | $186 |
| Amneal Pharmaceuticals LLC | 10 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $148 |
| Tonix Medicines, Inc. | 3 | $120 |
| Hikma Pharmaceuticals USA | 6 | $98 |
| Biodelivery Sciences International, Inc. | 7 | $94 |
| Averitas Pharma Inc. | 2 | $90 |
| Novo Nordisk | 4 | $89 |
| Currax Pharmaceuticals LLC | 6 | $81 |
| Scilex Pharmaceuticals Inc. | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| Lundbeck LLC | 2 | $47 |
| Amgen | 3 | $43 |
| Redhill Biopharma Inc. | 2 | $36 |
| Ardelyx, Inc. | 2 | $30 |
| Forte Bio-pharma LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Metacel Pharmaceuticals LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$122
- NURTEC ODT$112
How this compares
$5,111 in reported general payments places this provider in the 75th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 389 | $240,711 |
| Nucynta ErTapentadol Hcl | 111 | $120,263 |
| BelbucaBuprenorphine Hcl | 149 | $115,398 |
| OxycontinOxycodone Hcl | 157 | $93,484 |
| RelistorMethylnaltrexone Bromide | 28 | $64,952 |
| NucyntaTapentadol Hcl | 30 | $42,161 |
| Nurtec OdtRimegepant Sulfate | 29 | $35,059 |
| Fentanyl | 250 | $28,491 |
| Emgality PenGalcanezumab-Gnlm | 38 | $27,569 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 905 | $26,170 |
| Pregabalin | 894 | $22,209 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 767 | $21,982 |
| Oxycodone Hcl | 946 | $20,846 |
| Aimovig AutoinjectorErenumab-Aooe | 25 | $18,913 |
| Pregabalin ErPregabalin | 63 | $15,273 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca, Nucynta | $1,045 | $518,533679 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $392 | $64,95228 claims |
| PfizerNurtec Odt | $731 | $35,05929 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity, Trintellix | $148 | $19,54738 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $67 | $15,02014 claims |
| Redhill Biopharma Inc.Movantik | $36 | $11,19624 claims |
| Hikma Pharmaceuticals USABuprenorphine | $98 | $8,64238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 150 pain medicine providers in Virginia.
Other pain medicine in Broadway
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- George BaylorSalem$24K
- Jasmit BrarLansdowne$18K
- Christina ShinCharlottesville$18K
- Michael DepalmaRichmond$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.